Skip to content
Cyclodextrin News

Cyclodextrin News

A forum for researchers, students and applicants in the field of cyclodextrin technology

  • Home
  • Pharma applications
  • Non-pharma applications
  • CD derivatives
  • Events
  • E-ducation
September 11, 2026 CD derivatives / Non-pharma applications / Pharma applications

Special Issue titled “Cyclodextrins: Properties and Applications, 4th Edition”

The Special Issue titled “Cyclodextrins: Properties and Applications, 4th Edition” will be published in the International Journal of Molecular Sciences

Continue reading

September 9, 2026 Drug delivery / Pharma applications / Uncategorized

Enhancing Curcumin Efficacy Against Triple-Negative Breast Cancer

Researchers from Türkiye developed GE11-functionalized curcumin/carboxymethyl-β-cyclodextrin (Cur/CM-βCD) supramolecular assemblies, using GE11 as an EGFR-targeting peptide, to enhance the therapeutic potential

Continue reading

September 8, 2026 Drug delivery / Pharma applications

REVTORPYK™: A New FDA Approval for Gedatolisib/HPBCD composition

A new chapter in targeted cancer therapy On July 14, 2026, the U.S. FDA approved REVTORPYK™ (gedatolisib), developed by Celcuity,

Continue reading

September 11, 2026 CD derivatives / Non-pharma applications / Pharma applications

Special Issue titled “Cyclodextrins: Properties and Applications, 4th Edition”

The Special Issue titled “Cyclodextrins: Properties and Applications, 4th Edition” will be published in the International Journal of Molecular Sciences

Continue reading

golf balls on tees in the green grass
September 10, 2026 Non-pharma applications / Other industrial use

Cyclodextrins hit the golf course seven years ago — and they are still there

Golf balls may look simple, but they are highly engineered products. Their performance depends on carefully designed combinations of cores,

Continue reading

September 9, 2026 Drug delivery / Pharma applications / Uncategorized

Enhancing Curcumin Efficacy Against Triple-Negative Breast Cancer

Researchers from Türkiye developed GE11-functionalized curcumin/carboxymethyl-β-cyclodextrin (Cur/CM-βCD) supramolecular assemblies, using GE11 as an EGFR-targeting peptide, to enhance the therapeutic potential

Continue reading

September 8, 2026 Drug delivery / Pharma applications

REVTORPYK™: A New FDA Approval for Gedatolisib/HPBCD composition

A new chapter in targeted cancer therapy On July 14, 2026, the U.S. FDA approved REVTORPYK™ (gedatolisib), developed by Celcuity,

Continue reading

September 7, 2026 CD as API / Pharma applications

Reducing Cholesterol with β-CDP: Insights for NPC and AD

Niemann–Pick disease type C (NPC) and Alzheimer’s disease (AD) are neurodegenerative disorders characterised by cognitive dysfunction and neurological impairment. In

Continue reading

September 4, 2026 Uncategorized

9th China International Biotechnology Conference & Exhibition (BIOTEC-CHINA 2027)

BIOTEC-CHINA 2027 will be held from 23-25 April 2027 in Beijing Huanghe Jingdu Conference Center, Beijing China. BIOTEC-CHINA 2027 call

Continue reading

September 3, 2026 Drug delivery

Fast-Dissolving HPβCD Nanofibers with a combination of 3 drugs: A New Solution for Pain Relief

Researchers from the United States 🇺🇸 developed fast-dissolving HPβCD nanofibers containing a three-drug combination of aspirin, paracetamol, and caffeine commonly

Continue reading

a person wearing latex gloves using a microscope
September 2, 2026 CD derivatives / Diagnosis / Life sciences

Cyclodextrin Helps Analyzing 3D Histology of Archived Human Tissues

What if decades-old human tissue archives could be transformed from thin, two-dimensional histological sections into detailed three-dimensional maps of cells,

Continue reading

September 1, 2026 Drug delivery / Pharma applications

Advanced Electrospun Nanofibrous Architectures for Multidrug Delivery Systems

This review on electrospinning investigates how this techniqe can be applied for delivering multiple drugs by allowing precise control over

Continue reading

August 31, 2026 Drug delivery / Pharma applications

Enhancing Remdesivir Delivery: PJL Micelles vs SBECD Formulations

Remdesivir (REM), a nucleoside analogue that has been approved for SARS-CoV-2 treatment, is poorly soluble in water and is currently

Continue reading

Posts pagination

1 2 3 … 206 Next Posts»

Recent Posts

  • Special Issue titled “Cyclodextrins: Properties and Applications, 4th Edition”
  • Cyclodextrins hit the golf course seven years ago — and they are still there
  • Enhancing Curcumin Efficacy Against Triple-Negative Breast Cancer
  • REVTORPYK™: A New FDA Approval for Gedatolisib/HPBCD composition
  • Reducing Cholesterol with β-CDP: Insights for NPC and AD

Tags

alpha-CD atherosclerosis Cancer therapy Captisol Cholesterol Clinical trial conference Covid-19 cyclodextrin polymer Dexolve drug delivery drug delivery systems electrospinning FDA Food gamma-CD Gilead HPBCD hydrogel methyl BCD Nanoparticles Niemann Pick Disease RAMEB remdesivir review SBECD Special issue Sugammadex Synthesis

Follow Us

  • LinkedIn
  • X
  • Facebook

Categories

  • Agriculture (27)
  • Analysis (73)
  • CD as API (355)
  • CD derivatives (431)
  • Cosmetics and toilettry (54)
  • Diagnosis (15)
  • Drug delivery (816)
  • E-ducation (63)
  • Environmental (143)
  • Events (239)
  • Food (233)
  • Gene delivery (22)
  • Household products (6)
  • In Hungarian (4)
  • Life sciences (45)
  • Non-pharma applications (416)
  • Other industrial use (112)
  • Pharma applications (1,219)
  • Supramolecular systems (44)
  • Uncategorized (167)

Top Posts

  • Cyclodextrins hit the golf course seven years ago — and they are still there
  • Special Issue titled "Cyclodextrins: Properties and Applications, 4th Edition"
  • Practical Considerations about the Cyclodextrin Solubilities – A Quickstart Guide for Newbies
  • Cyclarity Unveils First-Ever Clinical Data Demonstrating Excretion of Oxidized Cholesterol, at American Heart Association Vascular Discovery Scientific Sessions
  • Enhancing Curcumin Efficacy Against Triple-Negative Breast Cancer
  • Lanosterol eye drops for cataract treatment
  • Cyclodextrins against skin aging
  • Cyclodextrin-assisted drug delivery to Central Nervous System: Mavenclad™ for multiple sclerosis treatment
  • REVTORPYK™: A New FDA Approval for Gedatolisib/HPBCD composition
  • Cyclodextrins to preserve and analyze whisky flavor

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 4,476 other subscribers
Loading Comments...